Brean Murray Downgrades Pharmasset to Hold, Removes PT

Symbols: VRUS
Share

Brean Murray has downgraded Pharmasset (NASDAQ: VRUS) from Buy to Hold and has removed its $105 price target.


 
 
< Previous
Buckingham Downgrades 99 Cents Only Stores to Neutral, $22 PT
Next >
Brean Murray Downgrades Pharmasset to "Hold"
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust